Logo image of 56S1.DE

SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Price, Quote, News and Overview

FRA:56S1 - Deutsche Boerse Ag - FR0013154002 - Common Stock - Currency: EUR

193  -2.6 (-1.33%)

56S1.DE Quote, Performance and Key Statistics

SARTORIUS STEDIM BIOTECH

FRA:56S1 (5/28/2025, 7:00:00 PM)

193

-2.6 (-1.33%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High277.5
52 Week Low144.1
Market Cap18.78B
Shares97.33M
Float27.74M
Yearly Dividend0.71
Dividend Yield0.35%
PE50.79
Fwd PE35
Earnings (Next)07-22 2025-07-22
IPO10-20 1994-10-20


56S1.DE short term performance overview.The bars show the price performance of 56S1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10 -15

56S1.DE long term performance overview.The bars show the price performance of 56S1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of 56S1.DE is 193 EUR. In the past month the price increased by 1.16%. In the past year, price decreased by -13.07%.

SARTORIUS STEDIM BIOTECH / 56S1 Daily stock chart

56S1.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 18.44 134.22B
1TMO.MI THERMO FISHER SCIENTIFIC INC 18.14 132.03B
DAP.DE DANAHER CORP 25.61 120.22B
1DHR.MI DANAHER CORP 24.62 116.11B
LO3.DE LONZA GROUP AG-REG 37.56 43.38B
DIM.PA SARTORIUS STEDIM BIOTECH 50.74 18.77B
SRT3.DE SARTORIUS AG-VORZUG 51.33 16.41B
SRT.DE SARTORIUS AG 41.31 13.21B
ILU.DE ILLUMINA INC 25.04 11.61B
ESF0.DE EUROFINS SCIENTIFIC 31.72 10.40B
ERF.PA EUROFINS SCIENTIFIC 31.52 10.34B
QIA.DE QIAGEN N.V. 19.38 8.48B

About 56S1.DE

Company Profile

56S1 logo image Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 9,961 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Company Info

SARTORIUS STEDIM BIOTECH

Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex

Aubagne PACA FR

Employees: 9961

56S1 Company Website

56S1 Investor Relations

Phone: 33442845600

SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ

What is the stock price of SARTORIUS STEDIM BIOTECH today?

The current stock price of 56S1.DE is 193 EUR. The price decreased by -1.33% in the last trading session.


What is the ticker symbol for SARTORIUS STEDIM BIOTECH stock?

The exchange symbol of SARTORIUS STEDIM BIOTECH is 56S1 and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is 56S1.DE stock listed?

56S1.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for SARTORIUS STEDIM BIOTECH stock?

18 analysts have analysed 56S1.DE and the average price target is 248.41 EUR. This implies a price increase of 28.71% is expected in the next year compared to the current price of 193. Check the SARTORIUS STEDIM BIOTECH stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SARTORIUS STEDIM BIOTECH worth?

SARTORIUS STEDIM BIOTECH (56S1.DE) has a market capitalization of 18.78B EUR. This makes 56S1.DE a Large Cap stock.


How many employees does SARTORIUS STEDIM BIOTECH have?

SARTORIUS STEDIM BIOTECH (56S1.DE) currently has 9961 employees.


What are the support and resistance levels for SARTORIUS STEDIM BIOTECH (56S1.DE) stock?

SARTORIUS STEDIM BIOTECH (56S1.DE) has a support level at 191.14 and a resistance level at 206.28. Check the full technical report for a detailed analysis of 56S1.DE support and resistance levels.


Is SARTORIUS STEDIM BIOTECH (56S1.DE) expected to grow?

The Revenue of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 8.49% in the next year. Check the estimates tab for more information on the 56S1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SARTORIUS STEDIM BIOTECH (56S1.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SARTORIUS STEDIM BIOTECH (56S1.DE) stock pay dividends?

SARTORIUS STEDIM BIOTECH (56S1.DE) has a dividend yield of 0.35%. The yearly dividend amount is currently 0.71. Check the full fundamental report for a detailed analysis of 56S1.DE dividend history, reliability and sustainability.


When does SARTORIUS STEDIM BIOTECH (56S1.DE) report earnings?

SARTORIUS STEDIM BIOTECH (56S1.DE) will report earnings on 2025-07-22.


What is the Price/Earnings (PE) ratio of SARTORIUS STEDIM BIOTECH (56S1.DE)?

The PE ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 50.79. This is based on the reported non-GAAP earnings per share of 3.8 and the current share price of 193 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 56S1.DE.


56S1.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 56S1.DE. When comparing the yearly performance of all stocks, 56S1.DE is a bad performer in the overall market: 88.32% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

56S1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE. 56S1.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

56S1.DE Financial Highlights

Over the last trailing twelve months 56S1.DE reported a non-GAAP Earnings per Share(EPS) of 3.8. The EPS increased by 4.97% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.15%
ROA 2.46%
ROE 5.14%
Debt/Equity 0.72
Chartmill High Growth Momentum
EPS Q2Q%34.88%
Sales Q2Q%11.65%
EPS 1Y (TTM)4.97%
Revenue 1Y (TTM)5.21%

56S1.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 79% to 56S1.DE. The Buy consensus is the average rating of analysts ratings from 18 analysts.

For the next year, analysts expect an EPS growth of 23.98% and a revenue growth 8.49% for 56S1.DE


Ownership
Inst Owners11.63%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts78.89
Price Target248.41 (28.71%)
EPS Next Y23.98%
Revenue Next Year8.49%